AU3916997A - Methods for the production of protein particles useful for delivery of pharmacological agents - Google Patents

Methods for the production of protein particles useful for delivery of pharmacological agents

Info

Publication number
AU3916997A
AU3916997A AU39169/97A AU3916997A AU3916997A AU 3916997 A AU3916997 A AU 3916997A AU 39169/97 A AU39169/97 A AU 39169/97A AU 3916997 A AU3916997 A AU 3916997A AU 3916997 A AU3916997 A AU 3916997A
Authority
AU
Australia
Prior art keywords
delivery
production
methods
pharmacological agents
protein particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39169/97A
Inventor
Neil Desai
Kevin Ferreri
Shlomo Magdassi
Patrick Soon-Shiong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Bioscience Inc
Original Assignee
American Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US2396896P priority Critical
Priority to US60023968 priority
Application filed by American Bioscience Inc filed Critical American Bioscience Inc
Priority to PCT/US1997/014661 priority patent/WO1998007410A1/en
Publication of AU3916997A publication Critical patent/AU3916997A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5169Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/22Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations
    • A61K49/222Echographic preparations; Ultrasound imaging preparation Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
AU39169/97A 1996-08-19 1997-08-19 Methods for the production of protein particles useful for delivery of pharmacological agents Abandoned AU3916997A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US2396896P true 1996-08-19 1996-08-19
US60023968 1996-08-19
PCT/US1997/014661 WO1998007410A1 (en) 1996-08-19 1997-08-19 Methods for the production of protein particles useful for delivery of pharmacological agents

Publications (1)

Publication Number Publication Date
AU3916997A true AU3916997A (en) 1998-03-06

Family

ID=21818165

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39169/97A Abandoned AU3916997A (en) 1996-08-19 1997-08-19 Methods for the production of protein particles useful for delivery of pharmacological agents

Country Status (4)

Country Link
EP (1) EP0938299A4 (en)
AU (1) AU3916997A (en)
CA (1) CA2263765C (en)
WO (1) WO1998007410A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254890B1 (en) 1997-12-12 2001-07-03 Massachusetts Institute Of Technology Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
WO2002061129A2 (en) * 2000-11-15 2002-08-08 Minerva Biotechnologies Corporation Oligonucleotide identifiers
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20040146564A1 (en) * 2001-04-05 2004-07-29 Muriel Subirade Process for making delivery matrix and uses thereof
CA2461349C (en) 2001-09-26 2011-11-29 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP4212921B2 (en) * 2002-03-29 2009-01-21 独立行政法人科学技術振興機構 Therapeutic agent and a hollow protein nanoparticles using protein hollow nanoparticles displaying antibodies
IL150906D0 (en) * 2002-07-25 2003-02-12 Yissum Res Dev Co Diagnostic microspheres
CN103405405A (en) 2002-12-09 2013-11-27 阿布拉西斯生物科学有限责任公司 Compositions and methods of delivery of pharmacological agents
FR2902007B1 (en) * 2006-06-09 2012-01-13 Flamel Tech Sa pharmaceutical formulations for the prolonged release of principle (s) active (s) and their particular therapeutic applications
NZ706745A (en) 2010-06-04 2017-01-27 Abraxis Bioscience Llc Methods of treatment of pancreatic cancer
EP2510930A1 (en) 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanoparticles comprising half esters of poly (methyl vinyl ether-co-maleic anhydride) and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6020059B2 (en) * 1980-09-16 1985-05-20 Snow Brand Milk Prod Co Ltd
US5585112A (en) * 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
GB9106686D0 (en) * 1991-03-28 1991-05-15 Hafslund Nycomed As Improvements in or relating to contrast agents
JP3482242B2 (en) * 1994-06-10 2003-12-22 株式会社キティー Microparticles and their preparation is enclosed in the physiologically active substance

Also Published As

Publication number Publication date
EP0938299A4 (en) 2001-01-17
EP0938299A1 (en) 1999-09-01
WO1998007410A1 (en) 1998-02-26
CA2263765A1 (en) 1998-02-26
CA2263765C (en) 2010-03-30

Similar Documents

Publication Publication Date Title
AU731208C (en) New foam-forming pharmaceutical composition
AU681266B2 (en) GNRH antagonists
AU694021B2 (en) Retreaded tires and method for making the same without spray cement
AU685612B2 (en) Method for the production of vehicle structures
EP0938571B8 (en) Method for the oligomerisation of peptides
AU7885498A (en) Selective acylation of epsilon-amino groups
AU5893696A (en) Modification of polypeptides
AU1461497A (en) Proteins Having Increased Stability
AU7274896A (en) Gemstone registration system
AU5273398A (en) Atomizer
AU1926899A (en) Exploiting genomics in the search for new drugs
IL117468D0 (en) Protein production and delivery
AU7678196A (en) Methods and compositions for the delivery of monomeric proteins
AU7587696A (en) Differentiation-suppressive polypeptide
AU4704097A (en) Interdental cleaner and process for its production
AU1444895A (en) Process for the preparation of leukotriene antagonists
AU4592997A (en) Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
AU4816397A (en) Process for bacterial production of polypeptides
AU2568797A (en) Enzyme-containing granules and process for the production thereof
AU3811495A (en) Antibodies
AU3885195A (en) Small particle formation
ZA9601344B (en) Process for the preparation of thietanones
AU4426296A (en) G protein coupled receptor protein, production, and use thereof
AU1943699A (en) Patterned coated articles and methods for producing the same
AU4864297A (en) Pyrimidine derivatives and processes for the preparation thereof